Try our beta test site
1 study found for:    15696196 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients
Condition: Melanoma
Interventions: Biological: group 1;   Biological: group 2;   Biological: group 3;   Biological: group 4

Study has passed its completion date and status has not been verified in more than two years.